Sfoglia per Rivista CANCERS
Beyond the guidelines: The grey zones of the management of gastric cancer. consensus statements from the gastric cancer Italian network (gain)
2021-01-01 Fornaro, L.; Spallanzani, A.; de Vita, F.; D'Ugo, D.; Falcone, A.; Lorenzon, L.; Tirino, G.; Cascinu, S.
Biomarkers and lung cancer early detection: State of the art
2021-01-01 Dama, E.; Colangelo, T.; Fina, E.; Cremonesi, M.; Kallikourdis, M.; Veronesi, G.; Bianchi, F.
Brain metastases from lung cancer: Is MET an actionable target?
2019-01-01 Stella, G. M.; Corino, A.; Berzero, G.; Kolling, S.; Filippi, A. R.; Benvenuti, S.
BRCA in gastrointestinal cancers: Current treatments and future perspectives
2020-01-01 Molinaro, E.; Andrikou, K.; Casadei Gardini, A.; Rovesti, G.
Breaching the blood–brain tumor barrier for tumor therapy
2021-01-01 Marcucci, F.; Corti, A.; Ferreri, A. J. M.
Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis
2023-01-01 Ferreri, A. J. M.; Zinzani, P. L.; Messina, C.; Valsecchi, D.; Rendace, M. C.; Premoli, E.; Giacomini, E.; Veronesi, C.; Degli Esposti, L.; Di Matteo, P.
Changes in the expression of pre-replicative complex genes in hTERT and ALT pediatric brain tumors
2020-01-01 Idilli, A. I.; Pagani, F.; Kerschbamer, E.; Berardinelli, F.; Bernabe, M.; Cayuela, M. L.; Piazza, S.; Poliani, P. L.; Cusanelli, E.; Mione, M. C.
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study
2023-01-01 Woyach, J. A.; Barr, P. M.; Kipps, T. J.; Barrientos, J. C.; Ahn, I. E.; Ghia, P.; Girardi, V.; Hsu, E.; Jermain, M.; Burger, J. A.
Chemoradiotherapy (Gemox plus helical tomotherapy) for unresectable locally advanced pancreatic cancer: A phase II study
2019-01-01 Passardi, A.; Scarpi, E.; Neri, E.; Parisi, E.; Ghigi, G.; Ercolani, G.; Gardini, A.; La Barba, G.; Pagan, F.; Casadei-Gardini, A.; Valgiusti, M.; Ferroni, F.; Frassineti, G. L.; Romeo, A.
The clinical and pathological profile of BRCA1 gene methylated breast cancer women: A meta-analysis
2021-01-01 Ruscito, I.; Gasparri, M. L.; De Marco, M. P.; Costanzi, F.; Besharat, A. R.; Papadia, A.; Kuehn, T.; Gentilini, O. D.; Bellati, F.; Caserta, D.
Clinical management of diffuse low-grade gliomas
2020-01-01 Lombardi, G.; Barresi, V.; Castellano, A.; Tabouret, E.; Pasqualetti, F.; Salvalaggio, A.; Cerretti, G.; Caccese, M.; Padovan, M.; Zagonel, V.; Ius, T.
Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise
2022-01-01 Bartolomei, M.; Berruti, A.; Falconi, M.; Fazio, N.; Ferone, D.; Lastoria, S.; Pappagallo, G.; Seregni, E.; Versari, A.
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
2020-01-01 Silvestris, Nicola; Brunetti, Oronzo; Bittoni, Alessandro; Cataldo, Ivana; Corsi, Domenico; Crippa, Stefano; D'Onofrio, Mirko; Fiore, Michele; Giommoni, Elisa; Milella, Michele; Pezzilli, Raffaele; Vasile, Enrico; Reni, Michele
Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review
2023-01-01 Chen, J. W.; Heidsma, C. M.; Engelsman, A. F.; Kabaktepe, E.; van Dieren, S.; Falconi, M.; Besselink, M. G.; Nieveen van Dijkum, E. J. M.
Clinically advanced pheochromocytomas and paragangliomas: A comprehensive genomic profiling study
2021-01-01 Bratslavsky, G.; Sokol, E. S.; Daneshvar, M.; Necchi, A.; Shapiro, O.; Jacob, J.; Liu, N.; Sanford, T. S.; Pinkhasov, R.; Goldberg, H.; Killian, J. K.; Ramkissoon, S.; Severson, E. A.; Huang, R. S. P.; Danziger, N.; Mollapour, M.; Ross, J. S.; Pacak, K.
Clinicopathological and Dermoscopic Baselines in Patients with Lynch Syndrome
2022-01-01 Paolino, Giovanni; Pampena, Riccardo; Di Nicola, Matteo Riccardo; Mercuri, Santo Raffaele
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies
2019-01-01 Cona, Ms; Lecchi, M; Cresta, S; Damian, S; Del Vecchio, M; Necchi, A; Poggi, Mm; Raggi, D; Randon, G; Ratta, R; Signorelli, D; Vernieri, C; de Braud, F; Verderio, P; Di Nicola, M
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects
2022-01-01 Gulde, S.; Foscarini, A.; April-Monn, S. L.; Genio, E.; Marangelo, A.; Satam, S.; Helbling, D.; Falconi, M.; Toledo, R. A.; Schrader, J.; Perren, A.; Marinoni, I.; Pellegata, N. S.
Comments on and Illustrations of the EFSUMB CEUS Guidelines: Transabdominal and Endoscopic Ultrasound Features of Intrapancreatic Metastases and the Role of Multiparametric Imaging and EUS-Guided Sampling in Rare Pancreatic Tumors
2023-01-01 Moller, K.; Jenssen, C.; Braden, B.; Hocke, M.; Yamashita, Y.; Arcidiacono, P. G.; Ignee, A.; D'Onofrio, M.; Fusaroli, P.; Bhutani, M. S.; Dong, Y.; Sun, S.; Faiss, S.; Dietrich, C. F.
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy?
2023-01-01 Marino, R; Ratti, F; Della Corte, A; Santangelo, D; Clocchiatti, L; Canevari, C; Magnani, P; Pedica, F; Casadei-Gardini, A; De Cobelli, F; Aldrighetti, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Beyond the guidelines: The grey zones of the management of gastric cancer. consensus statements from the gastric cancer Italian network (gain) | 1-gen-2021 | Fornaro, L.; Spallanzani, A.; de Vita, F.; D'Ugo, D.; Falcone, A.; Lorenzon, L.; Tirino, G.; Cascinu, S. | |
| Biomarkers and lung cancer early detection: State of the art | 1-gen-2021 | Dama, E.; Colangelo, T.; Fina, E.; Cremonesi, M.; Kallikourdis, M.; Veronesi, G.; Bianchi, F. | |
| Brain metastases from lung cancer: Is MET an actionable target? | 1-gen-2019 | Stella, G. M.; Corino, A.; Berzero, G.; Kolling, S.; Filippi, A. R.; Benvenuti, S. | |
| BRCA in gastrointestinal cancers: Current treatments and future perspectives | 1-gen-2020 | Molinaro, E.; Andrikou, K.; Casadei Gardini, A.; Rovesti, G. | |
| Breaching the blood–brain tumor barrier for tumor therapy | 1-gen-2021 | Marcucci, F.; Corti, A.; Ferreri, A. J. M. | |
| Burden of Illness in Follicular Lymphoma with Multiple Lines of Treatment, Italian RWE Analysis | 1-gen-2023 | Ferreri, A. J. M.; Zinzani, P. L.; Messina, C.; Valsecchi, D.; Rendace, M. C.; Premoli, E.; Giacomini, E.; Veronesi, C.; Degli Esposti, L.; Di Matteo, P. | |
| Changes in the expression of pre-replicative complex genes in hTERT and ALT pediatric brain tumors | 1-gen-2020 | Idilli, A. I.; Pagani, F.; Kerschbamer, E.; Berardinelli, F.; Bernabe, M.; Cayuela, M. L.; Piazza, S.; Poliani, P. L.; Cusanelli, E.; Mione, M. C. | |
| Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study | 1-gen-2023 | Woyach, J. A.; Barr, P. M.; Kipps, T. J.; Barrientos, J. C.; Ahn, I. E.; Ghia, P.; Girardi, V.; Hsu, E.; Jermain, M.; Burger, J. A. | |
| Chemoradiotherapy (Gemox plus helical tomotherapy) for unresectable locally advanced pancreatic cancer: A phase II study | 1-gen-2019 | Passardi, A.; Scarpi, E.; Neri, E.; Parisi, E.; Ghigi, G.; Ercolani, G.; Gardini, A.; La Barba, G.; Pagan, F.; Casadei-Gardini, A.; Valgiusti, M.; Ferroni, F.; Frassineti, G. L.; Romeo, A. | |
| The clinical and pathological profile of BRCA1 gene methylated breast cancer women: A meta-analysis | 1-gen-2021 | Ruscito, I.; Gasparri, M. L.; De Marco, M. P.; Costanzi, F.; Besharat, A. R.; Papadia, A.; Kuehn, T.; Gentilini, O. D.; Bellati, F.; Caserta, D. | |
| Clinical management of diffuse low-grade gliomas | 1-gen-2020 | Lombardi, G.; Barresi, V.; Castellano, A.; Tabouret, E.; Pasqualetti, F.; Salvalaggio, A.; Cerretti, G.; Caccese, M.; Padovan, M.; Zagonel, V.; Ius, T. | |
| Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise | 1-gen-2022 | Bartolomei, M.; Berruti, A.; Falconi, M.; Fazio, N.; Ferone, D.; Lastoria, S.; Pappagallo, G.; Seregni, E.; Versari, A. | |
| Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM) | 1-gen-2020 | Silvestris, Nicola; Brunetti, Oronzo; Bittoni, Alessandro; Cataldo, Ivana; Corsi, Domenico; Crippa, Stefano; D'Onofrio, Mirko; Fiore, Michele; Giommoni, Elisa; Milella, Michele; Pezzilli, Raffaele; Vasile, Enrico; Reni, Michele | |
| Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review | 1-gen-2023 | Chen, J. W.; Heidsma, C. M.; Engelsman, A. F.; Kabaktepe, E.; van Dieren, S.; Falconi, M.; Besselink, M. G.; Nieveen van Dijkum, E. J. M. | |
| Clinically advanced pheochromocytomas and paragangliomas: A comprehensive genomic profiling study | 1-gen-2021 | Bratslavsky, G.; Sokol, E. S.; Daneshvar, M.; Necchi, A.; Shapiro, O.; Jacob, J.; Liu, N.; Sanford, T. S.; Pinkhasov, R.; Goldberg, H.; Killian, J. K.; Ramkissoon, S.; Severson, E. A.; Huang, R. S. P.; Danziger, N.; Mollapour, M.; Ross, J. S.; Pacak, K. | |
| Clinicopathological and Dermoscopic Baselines in Patients with Lynch Syndrome | 1-gen-2022 | Paolino, Giovanni; Pampena, Riccardo; Di Nicola, Matteo Riccardo; Mercuri, Santo Raffaele | |
| Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies | 1-gen-2019 | Cona, Ms; Lecchi, M; Cresta, S; Damian, S; Del Vecchio, M; Necchi, A; Poggi, Mm; Raggi, D; Randon, G; Ratta, R; Signorelli, D; Vernieri, C; de Braud, F; Verderio, P; Di Nicola, M | |
| Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects | 1-gen-2022 | Gulde, S.; Foscarini, A.; April-Monn, S. L.; Genio, E.; Marangelo, A.; Satam, S.; Helbling, D.; Falconi, M.; Toledo, R. A.; Schrader, J.; Perren, A.; Marinoni, I.; Pellegata, N. S. | |
| Comments on and Illustrations of the EFSUMB CEUS Guidelines: Transabdominal and Endoscopic Ultrasound Features of Intrapancreatic Metastases and the Role of Multiparametric Imaging and EUS-Guided Sampling in Rare Pancreatic Tumors | 1-gen-2023 | Moller, K.; Jenssen, C.; Braden, B.; Hocke, M.; Yamashita, Y.; Arcidiacono, P. G.; Ignee, A.; D'Onofrio, M.; Fusaroli, P.; Bhutani, M. S.; Dong, Y.; Sun, S.; Faiss, S.; Dietrich, C. F. | |
| Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? | 1-gen-2023 | Marino, R; Ratti, F; Della Corte, A; Santangelo, D; Clocchiatti, L; Canevari, C; Magnani, P; Pedica, F; Casadei-Gardini, A; De Cobelli, F; Aldrighetti, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile